Pharma Surge
Pharma Surge
Intelligence Layer
🌍·Feb 6Devices

CHEMBIO RECEIVES $1.8 MILLION CARB-X GRANT TO DEVELOP A RAPID DIAGNOSTIC TEST FOR TYPHOID FEVER

Publisher

C
Chembio Diagnostics, Inc.

Global

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
Chembio Diagnostics, Inc.
Region
Global
Scope
Devices
Published
February 6, 2026

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Source route

Continue on chembio.com

Leave the platform to read the original full article on the publisher site.

Source: Chembio Diagnostics, Inc.

Scope: Devices

Open original article
CHEMBIO RECEIVES $1.8 MILLION CARB-X GRANT TO DEVELOP A RAPID DIAGNOSTIC TEST FOR TYPHOID FEVER | Pharma Surge